96 related articles for article (PubMed ID: 27412033)
21. Serum lipoprotein (a) is associated with increased risk of stroke in Chinese adults: A prospective study.
Zhang J; Du R; Peng K; Wu X; Hu C; Li M; Xu Y; Xu M; Wang S; Bi Y; Wang W; Lu J; Chen Y
Atherosclerosis; 2019 Oct; 289():8-13. PubMed ID: 31437611
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of lipoprotein(a) and the risk of myocardial infarction.
Ridker PM; Hennekens CH; Stampfer MJ
JAMA; 1993 Nov; 270(18):2195-9. PubMed ID: 8411602
[TBL] [Abstract][Full Text] [Related]
23. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Lipoprotein(a) levels between elderly and middle-aged men with coronary artery disease.
Cicek H; Bayil S; Zer Y; Celik A; Geyikli I
Ann N Y Acad Sci; 2007 Apr; 1100():179-84. PubMed ID: 17460176
[TBL] [Abstract][Full Text] [Related]
25. Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
Konishi H; Miyauchi K; Shitara J; Endo H; Wada H; Doi S; Naito R; Tsuboi S; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Am J Cardiol; 2016 Dec; 118(12):1781-1785. PubMed ID: 27712648
[TBL] [Abstract][Full Text] [Related]
26. Lp(a) lipoprotein in cerebrovascular disease and dementia.
Urakami K; Mura T; Takahashi K
Jpn J Psychiatry Neurol; 1987 Dec; 41(4):743-8. PubMed ID: 2969061
[TBL] [Abstract][Full Text] [Related]
27. Low serum magnesium levels are associated with increased risk of fractures: a long-term prospective cohort study.
Kunutsor SK; Whitehouse MR; Blom AW; Laukkanen JA
Eur J Epidemiol; 2017 Jul; 32(7):593-603. PubMed ID: 28405867
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients.
Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
Eur J Clin Invest; 2006 Feb; 36(2):91-7. PubMed ID: 16436090
[TBL] [Abstract][Full Text] [Related]
30. Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER).
Gaw A; Murray HM; Brown EA;
Atherosclerosis; 2005 Jun; 180(2):381-8. PubMed ID: 15910866
[TBL] [Abstract][Full Text] [Related]
31. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction.
Mitsuda T; Uemura Y; Ishii H; Takemoto K; Uchikawa T; Koyasu M; Ishikawa S; Miura A; Imai R; Iwamiya S; Ozaki Y; Kato T; Shibata R; Watarai M; Murohara T
Heart Vessels; 2016 Dec; 31(12):1923-1929. PubMed ID: 26936452
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study.
Cho JH; Lee DY; Lee ES; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
Int J Cardiol; 2016 Nov; 222():233-237. PubMed ID: 27497100
[TBL] [Abstract][Full Text] [Related]
34. Aggregation of lipoprotein(a) to apolipoprotein A-I underlying HDL dysfunction as a major coronary risk factor.
Onat A; Can G; Murat S; Ciçek G; Örnek E; Yüksel H
Anadolu Kardiyol Derg; 2013 Sep; 13(6):543-51. PubMed ID: 23835300
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population.
D'Angelo A; Ruotolo G; Garancini P; Sampietro F; Mazzola G; Calori G
Haematologica; 2006 Dec; 91(12):1613-20. PubMed ID: 17145597
[TBL] [Abstract][Full Text] [Related]
36. Low lipoprotein(a) concentration is associated with cancer and all-cause deaths: a population-based cohort study (the JMS cohort study).
Sawabe M; Tanaka N; Mieno MN; Ishikawa S; Kayaba K; Nakahara K; Matsushita S;
PLoS One; 2012; 7(4):e31954. PubMed ID: 22485129
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome.
Onat A; Hergenç G; Ozhan H; Kaya Z; Bulur S; Ayhan E; Can G
Coron Artery Dis; 2008 May; 19(3):125-31. PubMed ID: 18418227
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus.
Yun JS; Ahn YB; Song KH; Yoo KD; Park YM; Kim HW; Ko SH
Diabet Med; 2016 May; 33(5):639-43. PubMed ID: 26202453
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.
Danesh J; Collins R; Peto R
Circulation; 2000 Sep; 102(10):1082-5. PubMed ID: 10973834
[TBL] [Abstract][Full Text] [Related]
40. Low testosterone and the risk of dementia in elderly men: Impact of age and education.
Carcaillon L; Brailly-Tabard S; Ancelin ML; Tzourio C; Foubert-Samier A; Dartigues JF; Guiochon-Mantel A; Scarabin PY
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S306-14. PubMed ID: 24035146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
